Jane Street Group, LLC Acrivon Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$481 Billion
Q2 2025

A detailed history of Jane Street Group, LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 311,829 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

311,829

Holding current value

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	N/A	311,829 New	311,829 $0
Q2 2024 Aug 14, 2024	BUY	N/A	30,714 New	30,714 $0

Others Institutions Holding ACRV

# of Institutions

Shares Held

18.5M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

8.34M
Shares

$0
0.0% of portfolio
Sands Capital Ventures, LLC Arlington, VA

2.12M
Shares

$0
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

1.9M
Shares

$0
0.0% of portfolio
Wellington Management Group LLP Boston, MA

888K
Shares

$0
0.0% of portfolio
Black Rock Inc. New York, NY

767K
Shares

$0
0.0% of portfolio

View Full List

About Acrivon Therapeutics, Inc.

Ticker ACRV

More about ACRV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account